Refer your Patient for Psilocybin-Assisted Psychotherapy

TheraPsil is helping patients to access medical psilocybin -
Help your patient to join Project Solace and access legal psilocybin-assisted psychotherapy.

What is Project Solace?

Project Solace is the world's largest medical psilocybin access and data project. This project aims to expand legal access to psilocybin for patients in medical need, while developing a substantial body of evidence, using a real-world data registry. The real world data registry will document clinical effectiveness, safety, and clinician and patient reported outcomes in patients who have received medical psilocybin-assisted psychotherapy via the Special Access Program.

What is Psilocybin-Assisted Psychotherapy ?

Psilocybin-assisted psychotherapy refers to the professionally guided use of psilocybin (‘magic mushrooms’) in combination with psychotherapy.

TheraPsil’s clinical protocol encompasses careful medical oversight from trained multidisciplinary treatment teams with comprehensive psychotherapy before and after each psilocybin session. This therapy has been shown in numerous clinical studies to reduce existential distress, relieve depression and reduce or eliminate the fear of death.

Step 1 - Assess Suitability for Psilocybin-Assisted Psychotherapy

Step 1

TheraPsil has a growing network of TheraPsil Associate Prescribers (Doctors & Nurse Practitioners) able to oversee patients receiving access to medical psilocybin-assisted psychotherapy via the Special Access Program.

Each patient must first have a preliminary medical assessment completed by their community prescriber to see whether they are a potential candidate for psilocybin-assisted psychotherapy before a referral is requested.

Download our Patient Inclusion Criteria (PIC) form by clicking here and complete it with your patient.

Step 2 - Confirm Your Patient Has Completed Our Intake

Step 2

Step 3 - Complete Referral

Step 3

TheraPsil has an ever-growing pool of TheraPsil Physician Associates and treatment teams across Canada.

Any patient who has completed our electronic intake form has been added to our waitlist. We currently have an extensive waitlist. Assisting patients who reach out to us based on their immediate need, we are currently prioritizing applications for Canadians facing a palliative or active life-threatening diagnosis (such as cancer) first.

Patients on our waitlist will be notified directly at the email address they provide when there is a TheraPsil Physician Associates available to review their referral request. TheraPsil will provide your patient with our official referral form at that time. Your patient can then request you or any other community prescriber who supports them complete the referral.

Want to learn more about psilocybin-assisted psychotherapy?

Prescribers are encouraged to enroll in TheraPsil's 'Psilocybin Therapy Training Program'.
Learn more and sign up by visiting our training page.

To learn more now, visit our Frequently Asked Questions page

Do you have questions?

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE

The information, including but not limited to, text, graphics, images, educational content, supporting documents and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical education. We do not authorize or advise any practice, scope, diagnosis or treatment approach. All practitioners viewing this content are solely responsible for their own professional practice. TheraPsil, TheraPsil consultant and TheraPsil employees are in no way responsible for any health care professional’s practice.

Please Note: WE ARE COMMITTED TO COMPLETELY LEGAL BEHAVIOUR in our advocacy of psilocybin for medical purposes. Recommending the therapeutic use of a psychedelic substance, providing psychedelic psychotherapy, or referring an individual to a therapist for psychedelic therapy is currently illegal, as these actions can open us to the criminal charge of aiding and abetting the possession of a controlled substance.